52 min
Advocacy in Action: Coy Stout's Vision for Empowered Healthcare RealPharma: Conversations with Pharma Pathfinders
-
- Medicine
Trying to understand how pharma can effectively partner with patient advocates to support better patient outcomes?
In this episode, Coy Stout discusses his journey in patient advocacy and the intersection of patient advocacy, policy, and social work in the pharma industry. He shares personal stories that motivated him to get involved in the field and highlights the importance of patient-centricity in biotech companies.
Coy also discusses the role of technology in patient advocacy and the challenges and controversies surrounding patient advocacy in diseases like ALS and Alzheimer's. He emphasizes the need for transparency, collaboration, and patient input in decision-making processes, especially when it comes to drug pricing and access. In this episode, Coy Stout shares his insights on patient advocacy and the importance of patient-centered care. He discusses the challenges faced by patients and the need for more diverse representation in healthcare and pharma. Coy also highlights the transformative medicine happening now and the opportunity to bring real-world expertise into the industry. He envisions a future where patients and their caregivers are actively involved in guiding research and commercialization efforts.
Overall, Coy emphasizes the importance of creating space for patients and their communities to contribute to innovation in healthcare.
Chapters:
00:00 Introduction
01:32 Motivation for Patient Advocacy
04:38 Early Relationships Between Advocacy Groups and Pharma
07:08 Patient-Centricity in Biotech Companies
09:42 Gold Standard of Patient Advocacy
10:51 Intersection of Patient Advocacy and DEI Initiatives
12:45 Engaging Employees in Advocacy
17:34 Role of Technology in Patient Advocacy
20:50 Controversies and Challenges in Patient Advocacy
31:07 Patient Advocacy in ALS and Alzheimer's Disease
38:00 Balancing Patient Advocacy and Drug Pricing
54:53 Closing Remarks
Trying to understand how pharma can effectively partner with patient advocates to support better patient outcomes?
In this episode, Coy Stout discusses his journey in patient advocacy and the intersection of patient advocacy, policy, and social work in the pharma industry. He shares personal stories that motivated him to get involved in the field and highlights the importance of patient-centricity in biotech companies.
Coy also discusses the role of technology in patient advocacy and the challenges and controversies surrounding patient advocacy in diseases like ALS and Alzheimer's. He emphasizes the need for transparency, collaboration, and patient input in decision-making processes, especially when it comes to drug pricing and access. In this episode, Coy Stout shares his insights on patient advocacy and the importance of patient-centered care. He discusses the challenges faced by patients and the need for more diverse representation in healthcare and pharma. Coy also highlights the transformative medicine happening now and the opportunity to bring real-world expertise into the industry. He envisions a future where patients and their caregivers are actively involved in guiding research and commercialization efforts.
Overall, Coy emphasizes the importance of creating space for patients and their communities to contribute to innovation in healthcare.
Chapters:
00:00 Introduction
01:32 Motivation for Patient Advocacy
04:38 Early Relationships Between Advocacy Groups and Pharma
07:08 Patient-Centricity in Biotech Companies
09:42 Gold Standard of Patient Advocacy
10:51 Intersection of Patient Advocacy and DEI Initiatives
12:45 Engaging Employees in Advocacy
17:34 Role of Technology in Patient Advocacy
20:50 Controversies and Challenges in Patient Advocacy
31:07 Patient Advocacy in ALS and Alzheimer's Disease
38:00 Balancing Patient Advocacy and Drug Pricing
54:53 Closing Remarks
52 min